platoseed
Clear Genetics is scaling delivery of Genomic services
Clear Genetics is developing innovative, patient-centric software to thoughtfully integrate genetics into routine patient care. Our HIPAA-compliant platform offers an automated and comprehensive solution to deliver genetic services at scale. Clear Genetics serves leading health systems, clinics and commercial labs across the nation.
Clear Genetics appears to offer Invitae Gia, a HIPAA-compliant clinical chatbot that guides patients through genetic testing processes, including intake, education, results delivery, and scheduling with genetic counselors. It is designed to integrate into clinics and automate parts of the genetic testing workflow for cancer and related risk assessments.
Gia is a virtual Genetic Information Assistant chatbot that conducts patient intake (personal and family history), provides pre-test education, determines eligibility and appropriate tests (including cancer-related germline testing), automates order forms, delivers results, and can release results or coordinate with a genetic counselor. It supports link sharing to patients, digital intake, education, notifications to clinicians, electronic signing of orders, and automated appointment facilitation. The product is available to patients and clinicians in the US and is embedded in the Invitae portal for selecting result release types.
Who it’s for: Clinics and health systems conducting genetic testing, particularly for cancer, who want to automate patient intake, education, results delivery, and counselor coordination within their existing Invitae workflow.
Mention of deployment in clinics and health systems, user metrics (patients/doctors), and integration with Invitae portal; implies active adoption and traction within US clinical settings.
I'm dedicated to increasing access to genetic information. My previous company Clear Genetics was acquired NVTA in 2019, where I led the Software and Data organization. I also founded MorNetware, which developed Genometer a software that screens 90% of Israeli pregnancies for ethnic-based carrier screening since 2005. I was an officer in the IDF Elite software unit and studied Biomedical Engineering for my BA M.Sc. I have an MBA from the Wharton Business School and am a 2-time Y Combinator Alum.
I'm a co-founder and COO of Nest Genomics (W22). Until recently, I led SaaS teams at Invitae (NVTA), a global genetics company. I was the co-founder and COO of ClearGenetics (W17, acquired by Invitae), which developed innovative software for integrating genetics into routine care. Before that, I held senior product roles at Twitter, SnappyTV and Google/Motorola. I'm a Mammram Alum, hold a Bachelor’s in Computer Science and MBA from Duke and Tel-Aviv University.

Our tests help eradicate cancer by telling doctors whether they got…

Patient Intelligence Platform for Genetic Disease